An interventional study of NeuroSync Web-Based Auditory-Cognitive Training and How-To Video Viewing (Active Control) in Hearing Loss, Sensorineural and Hearing Loss, Bilateral, sponsored by Medipol University. Not yet recruiting at 5 sites in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Medipol University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of this clinical trial is to learn whether NeuroSync (Turkish: Nörosenkron), a 6-week, home-based, web-delivered auditory-cognitive training program, improves listening in noise in adults aged 18 to 65 years who use hearing aids in both ears for sensorineural hearing loss.
The main questions it aims to answer are:
Researchers will compare NeuroSync training with an active control condition (watching "how-to" videos on the same web platform) to see whether the training leads to greater improvement.
Participants will:
This is a multicenter, randomized, active-controlled, parallel-group trial with pre-test (T0) and post-test (T1) assessments. Adult bilateral hearing aid users are recruited from five hearing aid centers in collaboration with the Department of Audiology, Istanbul Medipol University.
After eligibility screening, written informed consent, and the baseline (T0) assessment, participants are randomized 1:1 to the NeuroSync training arm or the active control arm. Randomization is stratified by center, using computer-generated variable-size blocks. The allocation sequence is prepared and held by an independent person who is not involved in enrollment, training, or outcome assessment, and the allocation for each participant is disclosed only after T0 is complete. The trial is open label: participants, the team delivering the training, and the outcome assessor are aware of group assignment. In the HINT and the dual-task test, each response is scored by the assessor in view of the participant, and thresholds, reaction times, and medians are calculated by the test software.
NeuroSync is a Turkish-language, web-based program delivered at home (4 sessions per week for 6 weeks; 24 sessions; up to 30 minutes each). Sessions combine a music/rhythm warm-up, speech-in-noise listening tasks, working-memory and attention exercises, and a short narrative with comprehension questions. Content follows weekly daily-life themes, and difficulty increases gradually across the six weeks. Session completion and task performance are logged by the platform.
Participants in the active control arm continue routine hearing aid use and watch "how-to" videos on the same web platform, using individual log-in accounts so that viewing can be verified, on the same schedule and for the same session duration as the training arm. They receive no graded signal-to-noise ratio training, music-based or cognitive exercises, dual tasks, or performance feedback. Access to NeuroSync is offered to control participants after the study ends.
All assessments are performed at the centers with participants wearing their own bilateral hearing aids in their everyday program. The baseline (T0) assessment is completed within about 10 days before the intervention period, and the post-test (T1) assessment within about 10 days after the end of the 6-week period. The test order is SSQ12, HINT, dual-task listening-effort test, SMRT, and random gap detection test.
A minimum of 34 participants is required (repeated-measures within-between interaction, effect size f = 0.25, alpha = 0.05, power = 0.80); 40 participants (20 per arm) will be enrolled to allow for attrition. The primary outcome will be analyzed with a linear mixed model (group, time, and group-by-time interaction) following the intention-to-treat principle.
347 studies on the registry are indexed under Hearing Loss, Sensorineural; 102 are open to participants now.
This study's planned enrollment of 40 is above the median of 32 across 248 interventional studies indexed under Hearing Loss, Sensorineural.
Browse Hearing Loss, Sensorineural studies →Medipol University is the lead sponsor of 328 studies on the registry; 87 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants complete the NeuroSync (Nörosenkron) web-based auditory-cognitive training program at home: 4 sessions per week for 6 weeks (24 sessions, up to 30 minutes each), while continuing routine daily use of their own bilateral hearing aids (at least 8 hours per day).
Behavioral: NeuroSync Web-Based Auditory-Cognitive Training
Participants continue routine daily use of their own bilateral hearing aids (at least 8 hours per day) and watch "how-to" videos on the same web platform, with individual log-in accounts so that viewing is verified: 4 sessions per week for 6 weeks, matched in session duration to the training arm. No graded speech-in-noise training, music-based or cognitive exercises, dual tasks, or performance feedback are provided.
Behavioral: How-To Video Viewing (Active Control)
Turkish-language, home-based, web-delivered auditory-cognitive training: 4 sessions per week for 6 weeks (24 sessions, up to 30 minutes each). Each session combines a music/rhythm warm-up, speech-in-noise listening and comprehension tasks, working-memory, attention and dual-task exercises, and a short narrative with comprehension questions. Content follows weekly daily-life themes. Difficulty increases progressively across the six weeks: the signal-to-noise ratio of the speech-in-noise tasks becomes less favorable and the musical and cognitive demands increase. Task-specific feedback is given. Session completion, accuracy, and reaction times are logged by the platform.
Also known as: Nörosenkron
Participants watch "how-to" videos delivered through the same web platform as the training program, using individual user name and password log-in so that viewing can be verified: 4 sessions per week for 6 weeks, with the same session duration as the training arm. The condition is intended to balance study participation, exposure to auditory content, and researcher attention. It includes no graded signal-to-noise ratio training, music-based or cognitive exercises, dual tasks, or performance feedback. Participants continue routine daily hearing aid use.
Change in Speech Reception Threshold in Noise on the Turkish Hearing in Noise Test (HINT)
Adaptive signal-to-noise ratio (dB SNR) at which 50% of sentences are correctly recognized on the Turkish HINT. Tested in the sound field in a sound-treated booth with participants wearing their own bilateral hearing aids in their everyday program; speech and noise are presented from the same loudspeaker at 0 degrees azimuth, 1 m (S0N0), with noise fixed at 65 dB. Different sentence lists are used at T0 and T1. Change is calculated as T1 minus T0. Lower thresholds (a decrease) indicate better speech understanding in noise.
Time frame: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Dual-Task Cost 3 dB Below the HINT Threshold SNR
Dual-task cost (DTC) is the percent change in median secondary-task reaction time in the dual-task condition relative to the single-task (visual task alone) condition: DTC (%) = \[(dual-task median RT - single-task median RT) / single-task median RT\] x 100. The dual-task condition presents Turkish Matrix Test sentences in noise at a signal-to-noise ratio 3 dB below (less favorable than) the participant's HINT threshold measured on the same day. Change is calculated as T1 minus T0 (percentage points). Lower values (a decrease) indicate less listening effort.
Time frame: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Dual-Task Cost at the HINT Threshold SNR
Dual-task cost (DTC) is the percent change in median secondary-task reaction time in the dual-task condition relative to the single-task (visual task alone) condition: DTC (%) = \[(dual-task median RT - single-task median RT) / single-task median RT\] x 100. The dual-task condition presents Turkish Matrix Test sentences in noise at a signal-to-noise ratio equal to the participant's HINT threshold measured on the same day. Change is calculated as T1 minus T0 (percentage points). Lower values (a decrease) indicate less listening effort.
Time frame: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Dual-Task Cost 3 dB Above the HINT Threshold SNR
Dual-task cost (DTC) is the percent change in median secondary-task reaction time in the dual-task condition relative to the single-task (visual task alone) condition: DTC (%) = \[(dual-task median RT - single-task median RT) / single-task median RT\] x 100. The dual-task condition presents Turkish Matrix Test sentences in noise at a signal-to-noise ratio 3 dB above (more favorable than) the participant's HINT threshold measured on the same day. Change is calculated as T1 minus T0 (percentage points). Lower values (a decrease) indicate less listening effort.
Time frame: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Speech, Spatial and Qualities of Hearing Scale 12-Item Version (SSQ12) Score
Turkish SSQ12-A, a 12-item self-report questionnaire of everyday hearing ability, answered with reference to everyday listening with bilateral hearing aids. Each item is rated from 0 to 10; the scale score is the mean of the 12 items (range 0 to 10). Change is calculated as T1 minus T0. Higher scores (an increase) indicate better self-perceived hearing ability.
Time frame: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Speech Repetition Accuracy in the Dual-Task Listening-Effort Test
Percentage of trials in which at least 3 of the 5 words of the Turkish Matrix Test sentence are repeated correctly during the dual-task test, reported separately for each of the three signal-to-noise ratio conditions (3 dB below, at, and 3 dB above the HINT threshold). Change is calculated as T1 minus T0 (percentage points). Higher values indicate better performance. Supportive outcome used to interpret the reaction-time measures.
Time frame: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Spectral-Temporally Modulated Ripple Test (SMRT) Threshold
Spectro-temporal resolution threshold in ripples per octave (RPO) measured with SMRT software (three-interval forced-choice, adaptive 1-up/1-down procedure; threshold is the mean of the last six reversals), presented in the sound field at the participant's most comfortable level with bilateral hearing aids. Change is calculated as T1 minus T0. Higher values indicate better discrimination. Exploratory outcome.
Time frame: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Random Gap Detection Thresholds (Turkish RATET)
Shortest inter-stimulus gap in milliseconds at which two tones are perceived as two sounds, measured separately at 500, 1000, 2000, and 4000 Hz with the Turkish random gap detection test (gaps of 0 to 40 ms), presented in the sound field at the most comfortable level with bilateral hearing aids. If two sounds are not perceived at 40 ms, the result is recorded as greater than 40 ms (right-censored). Lower thresholds indicate better temporal resolution. Exploratory outcome.
Time frame: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Participant Satisfaction With the NeuroSync Program
Five-question satisfaction questionnaire developed by the investigators, administered only to the experimental arm. Responses are reported descriptively as the distribution of answers to each question.
Time frame: Post-test (T1, at the end of the 6-week intervention period)
Change in Dual-Task Median Reaction Time 3 dB Below the HINT Threshold SNR
Listening effort is assessed with a dual-task paradigm in the sound field with participants wearing their own bilateral hearing aids. Primary task: repetition of Turkish Matrix Test sentences in noise (noise fixed at 65 dB), presented at a signal-to-noise ratio 3 dB below (less favorable than) the participant's HINT threshold measured on the same day. Secondary task: a four-color visual choice reaction-time task (key press). The outcome is the median reaction time in milliseconds for trials with a correct color response and correct speech repetition (at least 3 of 5 words). Change is calculated as T1 minus T0. Lower values (a decrease) indicate less listening effort.
Time frame: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Dual-Task Median Reaction Time at the HINT Threshold SNR
Listening effort is assessed with a dual-task paradigm in the sound field with participants wearing their own bilateral hearing aids. Primary task: repetition of Turkish Matrix Test sentences in noise (noise fixed at 65 dB), presented at a signal-to-noise ratio equal to the participant's HINT threshold measured on the same day. Secondary task: a four-color visual choice reaction-time task (key press). The outcome is the median reaction time in milliseconds for trials with a correct color response and correct speech repetition (at least 3 of 5 words). Change is calculated as T1 minus T0. Lower values (a decrease) indicate less listening effort.
Time frame: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Dual-Task Median Reaction Time 3 dB Above the HINT Threshold SNR
Listening effort is assessed with a dual-task paradigm in the sound field with participants wearing their own bilateral hearing aids. Primary task: repetition of Turkish Matrix Test sentences in noise (noise fixed at 65 dB), presented at a signal-to-noise ratio 3 dB above (more favorable than) the participant's HINT threshold measured on the same day. Secondary task: a four-color visual choice reaction-time task (key press). The outcome is the median reaction time in milliseconds for trials with a correct color response and correct speech repetition (at least 3 of 5 words). Change is calculated as T1 minus T0. Lower values (a decrease) indicate less listening effort.
Time frame: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Plan to share: No — Individual participant data will not be deposited in a repository; requests may be considered by the investigators after publication. Any data provided would be coded and would not include names or other direct identifiers.
Start is estimated for Nov 2026; primary completion for Feb 2027, 3 months later.
Of 82 non-industry interventional studies with no phase under Hearing Loss, Sensorineural, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 83. This study's planned 3 months is below that.
Counting every sponsor, half of 162 studies reached it within 22 months; a quarter within 6 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.